Zobrazeno 1 - 10
of 21
pro vyhledávání: '"PHIRST-2"'
Autor:
Galiè, Nazzareno a, ⁎, 1, Denton, Christopher P. b, 2, Dardi, Fabio a, 3, Manes, Alessandra a, 4, Mazzanti, Gaia a, 5, Li, Baohui c, 6, Varanese, Lucio c, 7, Esler, Anne d, 8, Harmon, Cathi c, 9, Palazzini, Massimiliano a, 10
Publikováno v:
In International Journal of Cardiology 15 May 2017 235:67-72
Autor:
Cathi Harmon, Christopher P. Denton, Fabio Dardi, Massimiliano Palazzini, Alessandra Manes, Nazzareno Galiè, Baohui Li, Lucio Varanese, Anne Esler, Gaia Mazzanti
Background The primary objective of this post hoc analysis was to evaluate clinical outcomes of tadalafil in patients with pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD-PAH) compared with patients with idiopathi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b360a719364fccb117bdaba51e7980d2
http://hdl.handle.net/11585/589953
http://hdl.handle.net/11585/589953
Autor:
Oudiz, Ronald J. ⁎, ⁎, Brundage, Bruce H. †, Galiè, Nazzareno ‡, Ghofrani, Hossein Ardeschir §, Simonneau, Gerald ∥, Botros, Fady T. ¶, Chan, Melanie ¶, Beardsworth, Anthony ¶, Barst, Robyn J. #
Publikováno v:
In Journal of the American College of Cardiology 21 August 2012 60(8):768-774
Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs.
Autor:
Jin, Qi1,2 (AUTHOR) drjinqi@foxmail.com, Chen, Dandan1,2 (AUTHOR), Zhang, Xiaochun1,2 (AUTHOR), Zhang, Feng3 (AUTHOR), Zhong, Dongxiang4 (AUTHOR), Lin, Dawei1,2 (AUTHOR), Guan, Lihua1,2 (AUTHOR) guanlh111@sina.com, Pan, Wenzhi1,2 (AUTHOR) guanlh111@sina.com, Zhou, Daxin1,2 (AUTHOR) guanlh111@sina.com, Ge, Junbo1,2 (AUTHOR)
Publikováno v:
Pharmaceutics. Jun2023, Vol. 15 Issue 6, p1579. 24p.
Autor:
Otani, Naoyuki1 (AUTHOR), Tomoe, Takashi1 (AUTHOR), Kawabe, Atsuhiko1 (AUTHOR), Sugiyama, Takushi1 (AUTHOR), Horie, Yasuto1 (AUTHOR), Sugimura, Hiroyuki1 (AUTHOR), Yasu, Takanori1 (AUTHOR), Nakamoto, Takaaki1 (AUTHOR) takanaka@dokkyomed.ac.jp
Publikováno v:
Pharmaceuticals (14248247). Oct2022, Vol. 15 Issue 10, p1277-N.PAG. 19p.
Autor:
Ruaro, Barbara1 (AUTHOR) barbara.ruaro@yahoo.it, Salton, Francesco1 (AUTHOR) paola.confalonieri.24@gmail.com, Baratella, Elisa2 (AUTHOR) elisa.baratella@gmail.com, Confalonieri, Paola1 (AUTHOR) pietrogeri@gmail.com, Geri, Pietro1 (AUTHOR) riccardo.pozzan@asugi.sanita.fvg.it, Pozzan, Riccardo1 (AUTHOR) torricina@gmail.com, Torregiani, Chiara1 (AUTHOR) marco.confalonieri@asugi.sanita.fvg.it, Bulla, Roberta3 (AUTHOR) rbulla@units.it, Confalonieri, Marco1 (AUTHOR), Matucci-Cerinic, Marco4,5 (AUTHOR) marco.matuccicerinic@unifi.it, Hughes, Michael6,7 (AUTHOR) michael.hughes-6@postgrad.manchester.ac.uk
Publikováno v:
Diagnostics (2075-4418). Mar2022, Vol. 12 Issue 3, p616-616. 16p.
Publikováno v:
Angiology; May2021, Vol. 72 Issue 5, p411-425, 15p
Autor:
Anthony Beardsworth, Fady T. Botros, Ronald J. Oudiz, Robyn J. Barst, Bruce H. Brundage, Hossein Ardeschir Ghofrani, Nazzareno Galiè, Gérald Simonneau, Melanie Chan
Publikováno v:
Journal of the American College of Cardiology. 60:768-774
Objectives The aim of this study was to evaluate the long-term safety and durability of efficacy of tadalafil for pulmonary arterial hypertension. Background Tadalafil is an oral phosphodiesterase-5 inhibitor approved for PAH treatment. In the multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8606795ad9b0cd0e0fa85fb951d9555
https://doi.org/10.1016/j.jacc.2012.05.004
https://doi.org/10.1016/j.jacc.2012.05.004
Autor:
Ronald J, Oudiz, Bruce H, Brundage, Nazzareno, Galiè, Hossein Ardeschir, Ghofrani, Gerald, Simonneau, Fady T, Botros, Melanie, Chan, Anthony, Beardsworth, Robyn J, Barst
Publikováno v:
Journal of the American College of Cardiology. 60(8)
The aim of this study was to evaluate the long-term safety and durability of efficacy of tadalafil for pulmonary arterial hypertension.Tadalafil is an oral phosphodiesterase-5 inhibitor approved for PAH treatment. In the multicenter, placebo-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68aade166f8ab609f7dce97718cbf34f
https://pubmed.ncbi.nlm.nih.gov/22818063
https://pubmed.ncbi.nlm.nih.gov/22818063
Publikováno v:
Therapeutic Advances in Respiratory Disease; Jan2017, Vol. 11 Issue 1, p46-63, 18p